Cancer: is a disease in which abnormal cells divide uncontrollably and destroy body tissue. Cancerous tumors are malignant, which means they can spread into, or invade, nearby tissues.
-
MAR 20, 2024 | 9:00 AM
C.E. CREDITS
Nanovials are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell seq...
Deciphering somatic mosaicism in healthy tissues and clonal diversity in tumors necessitates single-cell analysis. High-quality genomic and transcriptomic data at the single-cell level depen...
FEB 29, 2024 | 3:00 PM
C.E. CREDITS
In recent years, small volume biopsies have been increasingly utilized for diagnosis of tumors in both primary and recurrent settings. Concomitantly, the numbers of ancillary studies for cha...
Mariana Kiehl (Sr. Applications Scientist at Roche Sequencing & Life Science) describes the KAPA Total Prep FFPE workflow, a novel single-tube method for combined sequencing of DNA and R...
Dr. Christopher E. Mason Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction Digital PCR for...
FEB 27, 2024 10:00am CET, 9:00am GMT
10:00am PT, 12:00pm CT, 1:00pm ET: Welcome 10:15am PT, 12:15pm CT, 1:15pm ET: Digital PCR for minimal residual disease research and cancer research Dr. Christopher E. Mason Professor of Geno...
FEB 27, 2024 9:30am IST, 12:00pm CST/SGT
10:00am PT, 12:00pm CT, 1:00pm ET: Welcome 10:15am PT, 12:15pm CT, 1:15pm ET: Digital PCR for minimal residual disease research and cancer research Dr. Christopher E. Mason Professor of Geno...
The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity, the pace of development has never been faster. Biopharmaceutical companies can&rsquo...
Current cancer research is hindered by the limitations of existing experimental systems, which fall short in demonstrating concordance with human studies. In this way, we aim to develop mode...